Clinical trial
Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine
NCT00168610 · Bandim Health Project, Other · Unknown status
Key facts
| NCT number | NCT00168610 |
|---|---|
| Title | Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine |
| Official title | Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries? Randomized Prospective Studies in Guinea-Bissau |
| Lead sponsor | Bandim Health Project, Other |
| Collaborators | March of Dimes Leiden University Medical Center Medical Research Council Unit, The Gambia |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infant Mortality, Morbidity |
| Intervention type | Drug |
| Interventions | Vitamin A |
| Enrollment | 7,600 |
| Start date | Nov 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 15, 2013 |
| Countries | Guinea-Bissau |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: